First Time Loading...

Augmedix Inc
NASDAQ:AUGX

Watchlist Manager
Augmedix Inc Logo
Augmedix Inc
NASDAQ:AUGX
Watchlist
Price: 2.71 USD 1.88% Market Closed
Updated: May 5, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

66.7m
+63%
Assets
Growth Rates:
1 Year
+98%
3 Years
+139%
5 Years
-
7 Years
-
10 Years
-
43.4m
+8%
Liabilities
Growth Rates:
1 Year
+35%
3 Years
+75%
5 Years
-
7 Years
-
10 Years
-
23.3m
+3 095%
Equity
Growth Rates:
1 Year
+1 486%
3 Years
+647%
5 Years
-
7 Years
-
10 Years
-

Balance Sheet Decomposition
Augmedix Inc

66.7m
Assets
43.4m
Liabilities
66.7m
Assets
43.4m
Liabilities
Current Assets 56.8m
Cash & Short-Term Investments 46.2m
Receivables 8.6m
Other Current Assets 2m
Non-Current Assets 9.9m
PP&E 9m
Other Non-Current Assets 930k
Current Liabilities 23.6m
Accounts Payable 721k
Accrued Liabilities 7.7m
Other Current Liabilities 15.2m
Non-Current Liabilities 19.8m
Long-Term Debt 15.3m
Other Non-Current Liabilities 4.5m

Balance Sheet
Augmedix Inc

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
10
10
21
41
21
46
Cash
10
10
21
41
21
46
Total Receivables
2
2
3
7
6
9
Accounts Receivables
2
2
3
7
6
9
Other Receivables
0
0
0
0
0
0
Other Current Assets
0
2
3
2
2
2
Total Current Assets
13
14
27
51
30
57
PP&E Net
1
1
1
1
3
9
PP&E Gross
1
1
1
1
3
9
Accumulated Depreciation
5
6
7
6
6
3
Other Long-Term Assets
0
0
0
0
1
1
Total Assets
14
N/A
16
+12%
28
+77%
52
+86%
34
-35%
67
+98%
Liabilities
Accounts Payable
0
1
0
1
2
1
Accrued Liabilities
2
3
3
4
6
8
Short-Term Debt
0
0
0
0
0
0
Current Portion of Long-Term Debt
0
3
7
2
4
5
Other Current Liabilities
6
7
7
7
8
10
Total Current Liabilities
9
13
16
14
19
24
Long-Term Debt
13
10
8
13
11
15
Other Liabilities
1
4
0
1
1
4
Total Liabilities
23
N/A
27
+18%
25
-8%
28
+13%
32
+15%
43
+35%
Equity
Common Stock
38
54
0
0
0
0
Retained Earnings
50
68
84
101
126
145
Additional Paid In Capital
3
3
87
125
128
169
Other Equity
0
0
0
0
0
1
Total Equity
9
N/A
11
-28%
3
N/A
24
+671%
1
-94%
23
+1 486%
Total Liabilities & Equity
14
N/A
16
+12%
28
+77%
52
+86%
34
-35%
67
+98%
Shares Outstanding
Common Shares Outstanding
27
27
27
37
37
49

See Also

Summary
AUGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
AUGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
AUGX stock valuation using valuation multiples.
Wall Street Estimates
AUGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
AUGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 134,300+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.